Pilulka Lekarny AS (XPRA:PINK) EBIT : Kč-165 Mil (TTM As of Dec. 2023)

Pilulka Lekarny AS EBIT Chart

Competitive Comparison of Pilulka Lekarny AS's EBIT

For the Pharmaceutical Retailers subindustry, Pilulka Lekarny AS's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pilulka Lekarny AS's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pilulka Lekarny AS's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Pilulka Lekarny AS's EV-to-EBIT falls into.

Pilulka Lekarny AS EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was Kč-165 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pilulka Lekarny AS  (XPRA:PINK) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Pilulka Lekarny AS's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

where

Note: The Operating Income data used here is one times the annual (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Pilulka Lekarny AS's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

where Working Capital is:

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Pilulka Lekarny AS's Earnings Yield (Joel Greenblatt) % for today is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pilulka Lekarny AS EBIT Related Terms

Thank you for viewing the detailed overview of Pilulka Lekarny AS's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Pilulka Lekarny AS Business Description